A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections

NCT00965848 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection
Cross Infection
Bacterial Infections
Pneumonia, Ventilator-Associated
Intra-abdominal Infections
Urinary Tract Infections

Interventions

DRUG: Doripenem

Sponsor

Janssen-Cilag Ltd.,Thailand